Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03423407 · ClinicalTrials.gov registry record
Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 30
- Enrollment target
NCT03423407: Clinical Trial study, sponsored by Washington University School of Medicine.
NCT03423407 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03423407 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this research proposal is to establish a mechanism to develop tools that will allow the investigators to measure the impact of magnetic resonance (MR) acquisition correction sequences for attenuation correction on positron emission tomography (PET) quantitation accuracy.
Primary Outcome
-PET images from PET/MRI with the MR derived attenuation correction will be compared to images generated with the CT attenuation correction from the standard of care PET/CT scan.
Interventions
- DEVICE Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-12-14 |
| Est. Completion | 2020-03-02 |
Why NCT03423407 stopped before completion
NCT03423407 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI) is the first listed.
NCT03423407 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03423407 about?
NCT03423407 is a clinical study titled "Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)". The purpose of this research proposal is to establish a mechanism to develop tools that will allow the investigators to measure the impact of magnetic resonance (MR) acquisition correction sequences for attenuation correction on positron emission tomography (PET) quantitation accuracy.
What is the current status of trial NCT03423407?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2017-12-14. Estimated completion is 2020-03-02.
What interventions are being tested in trial NCT03423407?
The interventions under investigation include: Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI) (DEVICE).
Who is sponsoring clinical trial NCT03423407?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI